Aneuploidy as a cause of impaired chromatin silencing and mating-type specification in budding yeast

  1. Wahid A Mulla
  2. Chris W Seidel
  3. Jin Zhu
  4. Hung-Ji Tsai
  5. Sarah E Smith
  6. Pushpendra Singh
  7. William D Bradford
  8. Scott McCroskey
  9. Anjali R Nelliat
  10. Juliana Conkright
  11. Allison Peak
  12. Kathryn E Malanowski
  13. Anoja G Perera
  14. Rong Li  Is a corresponding author
  1. Johns Hopkins University, United States
  2. Stowers Institute for Medical Research, United States
  3. Johns Hopkins, United States

Abstract

Aneuploidy and epigenetic alterations have long been associated with carcinogenesis, but it was unknown whether aneuploidy could disrupt the epigenetic states required for cellular differentiation. In this study, we found that ~3% of random aneuploid karyotypes in yeast disrupt the stable inheritance of silenced chromatin during cell proliferation. Karyotype analysis revealed that this phenotype was significantly correlated with gains of chromosomes III and X. Chromosome X disomy alone was sufficient to disrupt chromatin silencing and yeast mating-type identity as indicated by a lack of growth response to pheromone. The silencing defect was not limited to cryptic mating type loci and was associated with broad changes in histone modifications and chromatin localization of Sir2 histone deacetylase. The chromatin-silencing defect of disome X can be partially recapitulated by an extra copy of several genes on chromosome X. These results suggest that aneuploidy can directly cause epigenetic instability and disrupt cellular differentiation.

Data availability

The following data sets were generated

Article and author information

Author details

  1. Wahid A Mulla

    Department of Cell Biology, Johns Hopkins University, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3356-3902
  2. Chris W Seidel

    Genomics, Stowers Institute for Medical Research, Kansas City, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Jin Zhu

    Department of Cell Biology, Johns Hopkins, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Hung-Ji Tsai

    Cell Biology, Johns Hopkins, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Sarah E Smith

    Imaging Facility, Stowers Institute for Medical Research, Kansas City, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Pushpendra Singh

    Cell Biology, Johns Hopkins, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. William D Bradford

    Molecular Biology, Stowers Institute for Medical Research, Kansas City, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Scott McCroskey

    Molecular Biology, Stowers Institute for Medical Research, Kansas City, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Anjali R Nelliat

    Chemical and Biomolecular Engineering, Johns Hopkins, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Juliana Conkright

    Screening core, Stowers Institute for Medical Research, Kansas City, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Allison Peak

    Molecular Biology Core, Stowers Institute for Medical Research, Kansas City, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Kathryn E Malanowski

    Molecular Biology Core, Stowers Institute for Medical Research, Kansas City, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Anoja G Perera

    Molecular Biology, Stowers Institute for Medical Research, Kansas City, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Rong Li

    Cell Biology, Johns Hopkins, Baltimore, United States
    For correspondence
    rong@jhu.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0540-6566

Funding

National Institute of General Medical Sciences (R35-GM118172)

  • Rong Li

American Heart Association (15PRE25090204)

  • Wahid A Mulla

Prostate Cancer Foundation (16YOUN21)

  • Hung-Ji Tsai

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2017, Mulla et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,922
    views
  • 476
    downloads
  • 20
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Wahid A Mulla
  2. Chris W Seidel
  3. Jin Zhu
  4. Hung-Ji Tsai
  5. Sarah E Smith
  6. Pushpendra Singh
  7. William D Bradford
  8. Scott McCroskey
  9. Anjali R Nelliat
  10. Juliana Conkright
  11. Allison Peak
  12. Kathryn E Malanowski
  13. Anoja G Perera
  14. Rong Li
(2017)
Aneuploidy as a cause of impaired chromatin silencing and mating-type specification in budding yeast
eLife 6:e27991.
https://doi.org/10.7554/eLife.27991

Share this article

https://doi.org/10.7554/eLife.27991

Further reading

    1. Cell Biology
    Yajun Zhai, Peiyi Liu ... Gongzheng Hu
    Research Article

    Discovering new strategies to combat the multidrug-resistant bacteria constitutes a major medical challenge of our time. Previously, artesunate (AS) has been reported to exert antibacterial enhancement activity in combination with β-lactam antibiotics via inhibition of the efflux pump AcrB. However, combination of AS and colistin (COL) revealed a weak synergistic effect against a limited number of strains, and few studies have further explored its possible mechanism of synergistic action. In this article, we found that AS and EDTA could strikingly enhance the antibacterial effects of COL against mcr-1- and mcr-1+ Salmonella strains either in vitro or in vivo, when used in triple combination. The excellent bacteriostatic effect was primarily related to the increased cell membrane damage, accumulation of toxic compounds and inhibition of MCR-1. The potential binding sites of AS to MCR-1 (THR283, SER284, and TYR287) were critical for its inhibition of MCR-1 activity. Additionally, we also demonstrated that the CheA of chemosensory system and virulence-related protein SpvD were critical for the bacteriostatic synergistic effects of the triple combination. Selectively targeting CheA, SpvD, or MCR using the natural compound AS could be further investigated as an attractive strategy for the treatment of Salmonella infection. Collectively, our work opens new avenues toward the potentiation of COL and reveals an alternative drug combination strategy to overcome COL-resistant bacterial infections.

    1. Cell Biology
    Tamás Visnovitz, Dorina Lenzinger ... Edit I Buzas
    Short Report

    Recent studies showed an unexpected complexity of extracellular vesicle (EV) biogenesis pathways. We previously found evidence that human colorectal cancer cells in vivo release large multivesicular body-like structures en bloc. Here, we tested whether this large EV type is unique to colorectal cancer cells. We found that all cell types we studied (including different cell lines and cells in their original tissue environment) released multivesicular large EVs (MV-lEVs). We also demonstrated that upon spontaneous rupture of the limiting membrane of the MV-lEVs, their intraluminal vesicles (ILVs) escaped to the extracellular environment by a ‘torn bag mechanism’. We proved that the MV-lEVs were released by ectocytosis of amphisomes (hence, we termed them amphiectosomes). Both ILVs of amphiectosomes and small EVs separated from conditioned media were either exclusively CD63 or LC3B positive. According to our model, upon fusion of multivesicular bodies with autophagosomes, fragments of the autophagosomal inner membrane curl up to form LC3B positive ILVs of amphisomes, while CD63 positive small EVs are of multivesicular body origin. Our data suggest a novel common release mechanism for small EVs, distinct from the exocytosis of multivesicular bodies or amphisomes, as well as the small ectosome release pathway.